Dr. Louis Maletz, MD

Dr. Maletz practices at Poway Surgery Center in Poway, California.

Dr. Maletz's NPI, 1013983055, was assigned on February 28, 2006. Dr. Maletz graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Maletz holds California license G50801.

Dr. Maletz's primary practice is Poway Surgery Center, at 15611 Pomerado Rd, Poway, CA 92064. The practice phone is (858) 521-0031.

Dr. Maletz's primary practice is Poway Surgery Center in Poway, California. Dr. Maletz is also affiliated with Palomar UC San Diego Health Poway. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Maletz to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maletz practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Maletz's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Maletz is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Maletz's licenses on file in 2 states: California and New York.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, aneurysm, anxiety, arthritis, atrial fibrillation and flutter and benign or precancerous skin growths among the conditions Dr. Maletz treats.

CMS data shows 1,148 Medicare services from Dr. Maletz across 14 procedure codes in 2024, for 260 Medicare patients. Medicare paid $86,448 for them. Every service was in an office.

CMS counts 260 Medicare patients who saw Dr. Maletz in 2024. The largest group is 65 to 74, with 129 patients. 71% of them have high blood pressure, and 54% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Maletz's median patient age at 68, with 41% women.

In 2024, Dr. Maletz wrote 4,908 Medicare Part D claims for 411 patients. 89% of them were for generic drugs. CMS names the drug for 4,288 of them, across 96 drugs with 11 or more claims each, at $368,114 in total drug cost. In 2023, CMS named 4,096 claims across 93 drugs.

Dr. Maletz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maletz as offering telehealth. CMS counts 74 procedures of removal of skin lesions by Dr. Maletz, more than 74% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Maletz in 2013.

Dmand AI links Dr. Maletz to 1 clinical trial. Conditions studied include Constipation and Signs and Symptoms, Digestive.

CMS Open Payments shows 231 general payments to Dr. Maletz from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Novo Nordisk Inc paid the most, $1,544. It also lists 1 research payment totaling $700 in 2019.

Dmand AI lists 1 award for Dr. Maletz, most recently CMS Stage 1 EHR in 2011.

Dr. Maletz graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Maletz is a member of AMA and California Medical Association.

Dr. Maletz is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.